Premium
Vishakhapatnam-based drug ingredients maker Laurus Labs, which has true-blue private equity firm Warburg Pincus on board as an investor and is now planning an initial public offer, saw its revenue growth slowing phenomenally in 2014-15 vis-à-vis the previous two financial years. The company also recorded a steep decline of close ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
